Mechanistically, RHOV activates Jun N-terminal Kinase (JNK)/c-Jun signalling pathway, a critical pathway in lung cancer development and progression, and modulates the expression of markers of epithelial-to-mesenchymal transition (EMT), a process involved in cancer cell migration, invasion and metastasis. Here, JUN is linked to lung cancer.